WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

A BRIEF DIDACTIC APPROACH OF MEDICATION THERAPY MANAGEMENT USED FOR PARKINSON'S DISEASE

Kirti Rani* and Bishnu Parida

ABSTRACT

Parkinson is a pathological condition occurred due to degenerative disorder of central nervous system affecting the motor system. It results due to death of dopamine-generating cells in region of midbrain. It effects body movements including shivering of arms, legs, face, limb stiffness, slow motility, impaired functions in balance and coordination between body parts. Other common symptoms are depression, emotional breakdown, dysregulation of mood, speech problems, urinary problems, sleeplessness and skin problems. At present, there is no permanent cure for this disease and certain drugs available that helps in relieving from parkinsonism e.g. levodopa, pramipexole, dopamine agonists, MAO-B inhibitors, COMT inhibitors. Among them, levodopa and pramipexole are used initially to treat Parkinson. Levodopa is the most effective that get metabolized to dopamine in the brain by replacing biosynthetic precursor. It is also called as L-DOPA. In early onset of symptoms easily respond to L-DOPA treatment. Due to L-DOPA treatment, common symptoms such as motor disturbances, hallucinations, memory problems and confusion makes are respond well to consider Levodopa act as a standard treatment. Pramipexole is a non-ergot dopamine agonist which is effective in the treatment of this disease and major symptoms like fluctuations , dyskinesias, neuroprotection, dysregulation of mood, cardiac valvulopathy and somnipathy respond well when used with levodopa in combination with carbidopa. Common side effects called dyskinesia ocuured less when mediation with pramipexole is used as compared to treatment with levodopa. On other side, medication with levodopa lead to less occurrence in signs of edema. So, Levodopa and pramipexole are effective in dopaminergic therapy with divergent drug efficacy.

Keywords: Parkinson's disease; Levodopa; Pramipexole; dopamine; dopamine agonists; MAO-B inhibitors; COMT inhibitors.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More